FinalTitles
stringlengths 1
414
⌀ |
|---|
Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma |
Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma |
BI 894999 First in Human Dose Finding Study in Advanced Malignancies |
Combination Chemotherapy in Treating Patients With Advanced Cancer |
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma |
PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma |
Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma |
ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma |
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma |
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment |
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma |
A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies |
FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma |
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer |
A Safety Study of SGN-CD19A for B-Cell Lymphoma |
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies |
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With R/R B-NHL |
Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma |
Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients With Relapsed or Refractory B-cell NHL |
CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma |
Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies |
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma |
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients |